Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Marcoux

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Chest|December 21, 2023
Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity PneumonitisMonica L Mullin, Gustavo Fernandez, Daniel-Costin Marinescu, et al.
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Particulate Matter Associations with Lung Function in Pulmonary SarcoidosisSharon E Kim, Deborah Assayag, Matthew Broerman, et al.
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
Respiratory Medicine|December 27, 2021
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort studyColin J Adams, Shane Shapera, Christopher J Ryerson, et al.
Respiratory Research|December 8, 2020
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung diseaseAlyson W Wong, Tae Yoon Lee, Kerri A Johannson, et al.
Annals of the American Thoracic Society|May 25, 2021
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung DiseaseKerri A Johannson, Brendan C Lethebe, Deborah Assayag, et al.
Journal of Thoracic Disease|June 16, 2023
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohortVeronica Marcoux, Stacey Lok, Prosanta Mondal, et al.
Respirology (Carlton, Vic.)|March 4, 2024
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohortVeronica Marcoux, Stacey D Lok, Prosanta Mondal, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Chest|December 21, 2023
Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity PneumonitisMonica L Mullin, Gustavo Fernandez, Daniel-Costin Marinescu, et al.
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Particulate Matter Associations with Lung Function in Pulmonary SarcoidosisSharon E Kim, Deborah Assayag, Matthew Broerman, et al.
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
Respiratory Medicine|December 27, 2021
Effect of continued antifibrotic therapy after forced vital capacity decline in patients with idiopathic pulmonary fibrosis; a real world multicenter cohort studyColin J Adams, Shane Shapera, Christopher J Ryerson, et al.
Respiratory Research|December 8, 2020
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung diseaseAlyson W Wong, Tae Yoon Lee, Kerri A Johannson, et al.
Annals of the American Thoracic Society|May 25, 2021
Travel Distance to Subspecialty Clinic and Outcomes in Patients with Fibrotic Interstitial Lung DiseaseKerri A Johannson, Brendan C Lethebe, Deborah Assayag, et al.
Journal of Thoracic Disease|June 16, 2023
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohortVeronica Marcoux, Stacey Lok, Prosanta Mondal, et al.
Respirology (Carlton, Vic.)|March 4, 2024
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohortVeronica Marcoux, Stacey D Lok, Prosanta Mondal, et al.
Pageof 5